Press release from Companies
Published: 2020-04-24 08:43:50
On April 27th CMO Peter Michael Vestlev will present at the AACR Virtual Annual Meeting. The presentation is a 5 minutes video entitled "Clinical phase II study of SCO-101 - an inhibitor of SRPK1 and ABCG2 - restoring sensitivity to FOLFIRI in metastatic FOLFIRI resistant colorectal cancer patients"
The AACR Virtual Annual Meeting will feature a selection of high-impact proffered paper presentations. The program will include a number of clinical trial plenary sessions featuring more than 30 oral presentations along with perspectives on the science behind the clinical trials by experts discussants; clinical trial poster sessions; several minisymposia that showcase basic and translational science; and three New Drugs on the Horizon symposia that include first disclosures of innovative small molecules and biologics that have recently entered phase I clinical trials. The presentation will be at available from 9:00 a.m. - 6:00 p.m. (U.S. EDT). The abstract will be posted online at the AACR webpage at 12:01 a.m. EDT (U.S.) on Monday, April 27. The Virtual Meeting will be available free to everyone, although attendees will be asked to register to participate. Registration here: https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/
The presentation will be a part of the Session VPO.CT07.02 - Phase II Trials in Progress and the abstract is number 10343.
